Recent Updates
Recently added Catalysts
SIBN Positive Sentiment

SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026

Key Takeaway: SI-BONE, Inc. announced its participation in the TD Cowen 46th Annual Health Care Conference scheduled for March 2, 2026. The company will host a fireside chat at 7:30 a.m. PT. Investors can register for the call and access a live audio webcast on the company's website, which will be archived for 90 days.
Price reaction · baseline $15.25 (2026-02-17 close) · hit pre-market · clean, no other SIBN news in the window
day 0 close · peak
+3.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • SI-BONE is a leader in procedural solutions for compromised bone.
  • The company has a strong track record with over 140,000 procedures performed.
  • Management is actively engaging with investors through the conference.

Full Press Release Details

SANTA CLARA, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming TD Cowen 46th Annual Health Care Conference in Boston, MA. Management will be hosting a fireside chat on Monday, March 2, 2026, at 7:30 a.m. Pacific Time/ 10:30 a.m. Eastern Time.
Investors interested in listening to the conference call may do so by registering at this link:https://event.summitcast.com/view/9z5g2VrV6e6rbCqQgDRoHA/hkU3gw9TuYE3fDbRaRPY9r. Live audio of the webcast will be available on the “Investors” section of the company’s website at:www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.

About SI-BONE, Inc.

SI-BONE (NASDAQ: SIBN) is a global leader in developing procedural solutions to address clinical challenges associated with compromised bone. With expertise in biomechanical design and anatomy specific innovation, SI-BONE has built a technology platform with market-leading applications centered on the spinopelvic anatomy. SI-BONE continues to leverage the deep experience in addressing the challenges of low-density bone in the sacrum to develop unique technologies that are targeting new clinical adjacencies to help improve outcomes for patients with compromised bone. Since 2009, SI-BONE has supported physicians in performing a total of over 140,000 procedures. A unique body of clinical evidence supports the use of SI-BONE's technologies, including four randomized controlled trials and over 180 peer reviewed publications.
For additional information on the company or the products, including risks and benefits, please visitwww.si-bone.com.
SI-BONE® is a registered trademark of SI-BONE, Inc. ©2026 SI-BONE, Inc. All Rights Reserved.

Frequently Asked Questions

When is SI-BONE's presentation at the conference?

SI-BONE will present at the TD Cowen Conference on March 2, 2026.

How can investors listen to the conference call?

Investors can register for the conference call via a provided link.

Where can I find the archived webcast?

The archived webcast will be available on SI-BONE's website for at least 90 days.

What is SI-BONE known for?

SI-BONE is a leader in developing solutions for compromised bone.

Last updated: Feb 18, 2026